CALIMAN, ENRICO
 Distribuzione geografica
Continente #
EU - Europa 1.043
NA - Nord America 872
AS - Asia 503
SA - Sud America 50
OC - Oceania 21
AF - Africa 5
Totale 2.494
Nazione #
US - Stati Uniti d'America 863
RU - Federazione Russa 425
IT - Italia 301
HK - Hong Kong 151
SG - Singapore 138
CN - Cina 112
IE - Irlanda 96
PL - Polonia 55
BR - Brasile 45
IN - India 37
SE - Svezia 37
FI - Finlandia 33
FR - Francia 32
JO - Giordania 26
AU - Australia 21
DE - Germania 20
ID - Indonesia 19
NL - Olanda 12
CH - Svizzera 8
AT - Austria 7
CA - Canada 7
GB - Regno Unito 7
VN - Vietnam 6
BD - Bangladesh 3
CZ - Repubblica Ceca 3
NO - Norvegia 3
AR - Argentina 2
CI - Costa d'Avorio 2
CL - Cile 2
IL - Israele 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BE - Belgio 1
EG - Egitto 1
IQ - Iraq 1
JP - Giappone 1
KR - Corea 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
MX - Messico 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
TH - Thailandia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 2.494
Città #
Santa Clara 448
Hong Kong 133
Dublin 96
Singapore 88
Florence 57
Warsaw 53
Chandler 40
Ashburn 39
Milan 36
Rome 27
Hefei 26
Paris 26
Melbourne 21
Jakarta 19
Shanghai 17
Fairfield 16
Los Angeles 16
Boardman 15
Mumbai 15
Moscow 14
Helsinki 13
New York 13
Bengaluru 12
Seattle 12
Beijing 11
Turku 11
Altamura 9
Munich 9
Woodbridge 9
Buffalo 8
Lappeenranta 8
Lawrence 8
Pune 7
Vienna 7
Brescia 6
Naples 6
Kent 5
The Dalles 5
Bern 4
Boston 4
Houston 4
Princeton 4
Yubileyny 4
Zhengzhou 4
Alba 3
Ancona 3
Bremen 3
Nuremberg 3
Olomouc 3
Oslo 3
Recanati 3
San Diego 3
San Marco Evangelista 3
Turin 3
Wilmington 3
Abidjan 2
Andover 2
Anguillara Sabazia 2
Brusaporto 2
Cambridge 2
Carmignano 2
Catania 2
Chennai 2
Cinisello Balsamo 2
Curitiba 2
Dallas 2
Dhaka 2
Dong Ket 2
Faenza 2
Forlì 2
Formia 2
Geneva 2
Genoa 2
Lahore 2
Livorno 2
London 2
Messina 2
Mileto 2
Osimo 2
Ottawa 2
Palermo 2
Parma 2
Poggibonsi 2
Ribeirão Preto 2
Romola 2
Rufina 2
San Francisco 2
San Giovanni Valdarno 2
Santa Rita do Sapucaí 2
Scandicci 2
Siena 2
Stockholm 2
São Paulo 2
Tel Aviv 2
Toronto 2
Varese 2
Venice 2
Zurich 2
Amsterdam 1
Arezzo 1
Totale 1.506
Nome #
A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma. 214
Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer 150
Identification of predictive biomarkers of clinical benefits to immunotherapy in pre-treated advanced non-small cell lung cancer: a retrospective observational study 136
Ivosidenib in IDH1-mutated cholangiocarcinoma: Clinical evaluation and future directions 122
Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy 122
Italian survey of second tumors in patients with diagnosis of GIST (gastrointestinal stromal tumor) 116
Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification 105
Induction chemotherapy followed by pleurectomy decortication and hyperthermic intraoperative chemotherapy (Hithoc) for early-stage epitheliod malignant pleural mesothelioma—a prospective report 105
Chasing the target: New phenomena of resistance to novel selective ret inhibitors in lung cancer. updated evidence and future perspectives 102
Gender matters. Sex-related differences in immunotherapy outcome in patients with non-small cell lung cancer 100
Alteration of the Nucleotide Excision Repair (NER) Pathway in Soft Tissue Sarcoma 98
In Regard to "Activity of EGFR TKIs in Caucasian Patients With NSCLC Harbouring Potentially Sensitive Uncommon EGFR Mutations" 94
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 94
KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real-life population 93
Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors 90
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario 88
Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment 87
Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study 83
KRAS-related miR-143 expression is associated with lymph node involvement and correlates with outcome in pancreatic adenocarcinoma patients 82
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data 80
Long-term response of more than 9 years to regorafenib in a heavily pretreated patient with metastatic colorectal cancer 79
Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer 76
Liquid Biopsy and Non-small-cell Lung Cancer: Expecting More Fluid Management of Patients 74
Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients 70
Impact of natremia on metastatic non small cell lung cancer patients receiving immune checkpoint inhibitors 32
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 26
Genetic signatures of ERCC1 and ERCC2 expression, along with SNPs variants, unveil favorable prognosis in SCLC patients undergoing platinum-based chemotherapy 22
The emerging HER2 landscape in colorectal cancer: the key to unveil the future treatment algorithm? 15
Totale 2.555
Categoria #
all - tutte 9.756
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.756


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 0 0 1
2020/202143 3 7 0 6 3 3 3 4 4 6 0 4
2021/202227 0 2 1 0 0 2 2 5 0 2 3 10
2022/2023302 7 27 5 29 15 52 45 37 47 13 16 9
2023/2024358 10 14 27 19 24 47 23 77 11 19 35 52
2024/20251.750 63 161 93 274 392 223 60 107 99 61 106 111
Totale 2.555